Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 184

The DOI matches its Crossref record.

Impact of Cilostazol on Restenosis After Percutaneous Coronary Balloon Angioplasty

Open access
Tsuchikane, Etsuo, Fukuhara, Atsunori, Kobayashi, Tohru, Kirino, Motohiro, Yamasaki, Keita, Kobayashi, Tomoko, Izumi, Masahiro, Otsuji, Satoru, Tateyama, Hitone, Sakurai, Makoto, Awata, Nobuhisa · 1999 · Circulation

Abstract

Background —Restenosis after percutaneous transluminal coronary (balloon) angioplasty (PTCA) remains a major drawback of the procedure. We previously reported that cilostazol, a platelet aggregation inhibitor, inhibited intimal proliferation after directional coronary atherectomy and reduced the restenosis rate in humans. The present study aimed to determine the effect of cilostazol on restenosis after PTCA. Methods and Results —Two hundred eleven patients with 273 lesions who underwent successful PTCA were randomly assigned to the cilostazol (200 mg/d) group or the aspirin (250 mg/d) control group. Administration of cilostazol was initiated immediately after PTCA and continued for 3 months of follow-up. Quantitative coronary angiography was performed before PTCA and after PTCA and at follow-up. Reference diameter, minimal lumen diameter, and percent diameter stenosis (DS) were measured by quantitative coronary angiography. Angiographic restenosis was defined as DS at follow-up >50%. Eligible follow-up angiography was performed in 94 patients with 123 lesions in the cilostazol group and in 99 patients with 129 lesions in the control group. The baseline characteristics and results of PTCA showed no significant difference between the 2 groups. However, minimal lumen diameter at follow-up was significantly larger (1.65±0.55 vs 1.37±0.58 mm; P <0.0001) and DS was significantly lower (34.1±17.8% vs 45.6±19.3%; P <0.0001) in the cilostazol group. Restenosis and target lesion revascularization rates were also significantly lower in the cilostazol group (17.9% vs 39.5%; P <0.001 and 11.4% vs 28.7%; P <0.001). Conclusions —Cilostazol significantly reduces restenosis and target lesion revascularization rates after successful PTCA.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.cir.100.1.21

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 184

Metadata

Authors
Tsuchikane, E., Fukuhara, A., Kobayashi, T., Kirino, M., Yamasaki, K., Kobayashi, T., Izumi, M., Otsuji, S., Tateyama, H., Sakurai, M., & Awata, N.
Venue
Circulation
Published
1999-07-06
Volume
100
Issue
1
Pages
21-26
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W1993157664
Cited by
184
References
0
FWCI
17.84
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Impact of Cilostazol on Restenosis After Percutaneous Coronary Balloon Angioplasty. https://app.cochat.ai/papers/10.1161/01.cir.100.1.21
The paper
Tsuchikane, E., Fukuhara, A., Kobayashi, T., Kirino, M., Yamasaki, K., Kobayashi, T., Izumi, M., Otsuji, S., Tateyama, H., Sakurai, M., & Awata, N. (1999). Impact of Cilostazol on Restenosis After Percutaneous Coronary Balloon Angioplasty. Circulation. https://doi.org/10.1161/01.cir.100.1.21

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.